This inventor holds 2 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., The General Hospital Corporation. Active years: 2016-2018.
Company Filing History:
2 out of 8,573 
2 out of 480 
2 out of 3,068 
Years Active: 2016-2018
Title: **Innovator Spotlight: Alexandra Naba and Her Contributions to Cancer Research**
Introduction
Alexandra Naba is an accomplished inventor based in Cambridge, MA, known for her innovative contributions to cancer research. With a focus on identifying cancer-related extracellular matrix signatures, she holds two patents that significantly advance the detection and treatment of various cancers. Her work emphasizes the role of extracellular matrix proteins in cancer diagnosis and therapy.
Latest Patents
Naba's latest patents revolve around the discovery of cancer-related extracellular matrix signatures and the development of proteomic methods for identifying cancer-related proteins. These patents detail the identification of cancer-specific proteins associated with various aspects of cancer through proteomics analyzes of tissue samples from cancer patients. Notably, her research provides valuable panels or signature sets of proteins that can aid in the detection, diagnosis, and treatment of cancers and assist in monitoring therapeutic progress in patients. Her methods also facilitate the targeting of imaging and therapeutic agents to tumors by binding to specific proteins, with particular utility in colon cancer patients.
Career Highlights
Throughout her career, Alexandra Naba has collaborated with esteemed institutions, including the Massachusetts Institute of Technology and The General Hospital Corporation. Her innovative work in cancer research positions her as a leading figure in the application of proteomic strategies to clinical challenges, particularly in oncology.
Collaborations
Naba has partnered with prominent researchers such as Richard O. Hynes and Karl Clauser. These collaborations have furthered her research endeavors and have played a critical role in enhancing the understanding of cancer biology.
Conclusion
Alexandra Naba's contributions to cancer research underscore the vital intersection of innovation and healthcare. Through her patents, she has established herself as a key inventor in the field, paving the way for advancements in cancer diagnosis and therapeutic strategies. Her work continues to inspire future innovations aimed at improving patient outcomes in the fight against cancer.